All articles tagged: Alzheimer's disease with early onset (G30.0)

For patients with mild cognitive impairment (MCI) or early dementia due to Alzheimer disease (AD), comprehensive lifestyle changes may improve cognition and function, according to a study published online June 7 in Alzheimer's Research & Therapy.Dean Ornish, M.D., from Preventive Medicine Research Institute in Sausalito, Californi

Johannes Gutenberg University Mainz researchers identify a novel RNA modification causing mitochondrial dysfunction in Alzheimer's, impacting brain energy supply. This discovery, published in Molecular Psychiatry, enhances understanding of the disease's mechanisms and involves collaborative research efforts.

The Allen Institute, founded by Paul Allen in 2003, embarked on an ambitious mission to map the 86 billion neurons of the human brain. This endeavor aims to decode the intricate workings of the brain and provide insights into various neurological diseases.

The FDA is conducting further safety and effectiveness assessments of Eli Lilly's experimental Alzheimer's drug. This move follows concerns raised by its advisory panel regarding the drug's efficacy and side effects. The FDA's review aims to provide more clarity on the potential risks and benefits of the medication.

Metformin, a frontline treatment for type 2 diabetes, has long been a pharmaceutical mainstay, with over 91 million prescriptions in 2021 alone. However, recent evidence suggests that metformin's efficacy extends beyond diabetes management, encompassing various conditions such as cancer, obesity, liver disease, cardiovascular issues, neurodegenerative disorders, and renal diseases. As research exp

A study suggests a possible link between mouth herpes simplex virus and dementia. Researchers found higher levels of the virus in the brains of people with Alzheimer's disease. This association raises questions about the role of viral infections in neurodegenerative conditions.

Monoclonal antibodies targeting amyloid provide small benefits on cognitive and functional scales, which do not meet the minimal clinically important difference, according to a review published in the January/February issue of the Annals of Family Medicine.Mark H. Ebell, M.D., from the University of Georgia in Athens, and colleagues con

Researchers identified five distinct subtypes of Alzheimer's disease, each with unique cerebrospinal fluid protein profiles and genetic markers, suggesting the need for tailored treatments for each subtype.

Recent research suggests that visceral fat, fat around the organs, could heighten the risk of Alzheimer's disease. This risk is present regardless of overall body weight and is linked to early brain changes related to Alzheimer's, emphasizing the importance of managing this type of fat.

Higher consumption of whole grains is associated with a slower rate of global cognitive decline, according to a study published online Nov. 22 in Neurology.Xiaoran Liu, Ph.D., from Rush University Medical Center in Chicago, and colleagues examined the association of whole-grain consumption with longitudinal change in global cognition